SCHEMBL5032528

SCHEMBL5032528

COc1cc(Nc2nc(C(=O)O)cs2)ccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.51
ALOX5 P09917 1/20 0.51
GRM4 Q14833 2/20 0.50
HPGDS O60760 1/20 0.50
CSNK2A1 P68400 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ALDH1A1 P00352 1/20 0.49
AMY1A P0DUB6 6/20 0.48
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525319 0.84 KDM1A (0.55) KDM1AALOX5AMY1AMEN1MAPT
SCHEMBL21852321 0.81 MEN1 (0.56) KDM1AALDH1A1PRMT5WDR77MEN1
SCHEMBL525597 0.79 CSNK2A1 (0.65) ALOX5CSNK2A1AMY1AMEN1MAPT
SCHEMBL5372832 0.79 AMY1A (0.46) KDM1AALOX5HPGDSCSNK2A1ALDH1A1
SCHEMBL4915995 0.78 MEN1 (0.58) ALOX5CSNK2A1ALDH1A1MEN1MAPT
SCHEMBL4937005 0.78 DHODH (0.56) KDM1AGRM4CSNK2A1ALDH1A1MEN1
SCHEMBL2331462 0.77 CSNK2A1 (0.50) KDM1AALOX5HPGDSCSNK2A1ALDH1A1
SCHEMBL525682 0.77 KDM1A (0.76) KDM1AALOX5ALDH1A1AMY1AMEN1
SCHEMBL2878623 0.77 MAPT (0.44) GRM4HDAC6ALDH1A1MEN1MAPT
SCHEMBL2324801 0.77 PSEN1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP disclosed
EP-1694673-A1 NOVEL THIAZOLE DERIVATES F.HOFFMANN-LA ROCHE AG (CH) 2006-08-30 EP disclosed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed
WO-2005058887-A1 NOVEL THIAZOLE DERIVATES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 KDM1A 3213/4885ALOX5 2044/4885GRM4 514/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.